Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
In Vivo ; 38(2): 665-673, 2024.
Article in English | MEDLINE | ID: mdl-38418101

ABSTRACT

BACKGROUND/AIM: Particular matter 2.5 (PM2.5) pollution is associated with senescence induction. Since the impact of PM2.5 on stem cell senescence and potential compounds capable of reversing this process are largely unknown, this study aimed to examine the senescence effects of PM2.5 on dermal papilla (DP) stem cells. Additionally, we explored the reversal of these effects using natural product-derived substances, such as resveratrol (Res) or Emblica fruits, soybean, and Thunbergia Laurifolia (EST) extract. MATERIALS AND METHODS: Cell senescence was determined using the ß-Galactosidase (SA-ß-gal) assay. The senescence-associated secretory phenotype (SASP) was detected using real-time RT-PCR. For senescence markers, the mRNA and protein levels of p21 and p16 were measured using real-time RT-PCR and immunofluorescence analysis. RESULTS: Subtoxic concentration of PM2.5 (50 µg/ml) induced senescence in DP cells. Resveratrol (50, 100 µM) and plant extracts (400, 800 µg/ml) reversed PM2.5-induced cell senescence. Treatment with Res or EST significantly decreased SA-ß-gal staining in PM2.5-treated cells. Furthermore, Res and EST decreased the mRNA levels of SASP, including IL1α, IL7, IL8, and CXCL1. DP cells exposed to PM2.5 exhibited an increase in p21 and p16 mRNA and protein levels, which could be reversed by the addition of Res or EST. Res and EST could reduce p21 and p16 in senescent cells approximately 3- and 2-fold, respectively, compared to untreated senescent cells. CONCLUSION: PM2.5 induced senescence in human DP stem cells. Res and EST extract potentially reverse the senescence phenotypes of such cells.


Subject(s)
Cellular Senescence , Plant Extracts , Humans , Resveratrol/pharmacology , Cellular Senescence/genetics , RNA, Messenger/genetics , Plant Extracts/pharmacology , Particulate Matter
2.
Epigenomics ; 12(17): 1543-1558, 2020 09.
Article in English | MEDLINE | ID: mdl-32901510

ABSTRACT

Aim: The contribution of miRNAs as epigenetic regulators of sexually dimorphic gene expression in the placenta is unknown. Materials & methods: 382 placentas from the extremely low gestational age newborns (ELGAN) cohort were evaluated for expression levels of 37,268 mRNAs and 2,102 miRNAs using genome-wide RNA-sequencing. Differential expression analysis was used to identify differences in the expression based on the sex of the fetus. Results: Sexually dimorphic expression was observed for 128 mRNAs and 59 miRNAs. A set of 25 miRNA master regulators was identified that likely contribute to the sexual dimorphic mRNA expression. Conclusion: These data highlight sex-dependent miRNA and mRNA patterning in the placenta and provide insight into a potential mechanism for observed sex differences in outcomes.


Subject(s)
Epigenesis, Genetic , Epigenomics , Gene Expression Regulation , MicroRNAs/genetics , Placenta/metabolism , Sex Determination Processes/genetics , Epigenomics/methods , Female , Gene Expression Profiling , Gene Regulatory Networks , Humans , Pregnancy , RNA Interference , RNA, Messenger/genetics , Sex Characteristics , Transcriptome
3.
Toxicol Appl Pharmacol ; 316: 36-47, 2017 02 01.
Article in English | MEDLINE | ID: mdl-28025110

ABSTRACT

Early-life exposure to arsenic increases risk of developing a variety of non-malignant and malignant diseases. Arsenic-induced carcinogenesis may be mediated through epigenetic mechanisms and pathways leading to inflammation. Our previous study reported that prenatal arsenic exposure leads to increased mRNA expression of several genes related to inflammation, including COX2, EGR1, and SOCS3. This study aimed to investigate the effects of arsenic exposure on promoter DNA methylation and mRNA expression of these inflammatory genes (COX2, EGR1, and SOCS3), as well as the generation of 8-nitroguanine, which is a mutagenic DNA lesion involved in inflammation-related carcinogenesis. Prenatally arsenic-exposed newborns had promoter hypomethylation of COX2, EGR1, and SOCS3 in cord blood lymphocytes (p<0.01). A follow-up study in these prenatally arsenic-exposed children showed a significant hypomethylation of these genes in salivary DNA (p<0.01). In vitro experiments confirmed that arsenite treatment at short-term high doses (10-100µM) and long-term low doses (0.5-1µM) in human lymphoblasts (RPMI 1788) caused promoter hypomethylation of these genes, which was in concordance with an increase in their mRNA expression. Additionally, the level of urinary 8-nitroguanine was significantly higher (p<0.01) in exposed newborns and children, by 1.4- and 1.8-fold, respectively. Arsenic accumulation in toenails was negatively correlated with hypomethylation of these genes and positively correlated with levels of 8-nitroguanine. These results indicated that early-life exposure to arsenic causes hypomethylation of COX2, EGR1, and SOCS3, increases mRNA expression of these genes, and increases 8-nitroguanine formation. These effects may be linked to mechanisms of arsenic-induced inflammation and cancer development later in life.


Subject(s)
Arsenic/toxicity , Cyclooxygenase 2/metabolism , DNA Methylation/physiology , Early Growth Response Protein 1/metabolism , Guanine/analogs & derivatives , Suppressor of Cytokine Signaling 3 Protein/metabolism , Biomarkers/metabolism , Biomarkers/urine , Child , Cyclooxygenase 2/genetics , DNA Methylation/drug effects , Early Growth Response Protein 1/genetics , Environmental Exposure , Female , Fetal Blood/drug effects , Fetal Blood/metabolism , Follow-Up Studies , Guanine/urine , Humans , Infant, Newborn , Inflammation Mediators/metabolism , Male , Nails/chemistry , Nails/drug effects , Nails/metabolism , Pregnancy , Suppressor of Cytokine Signaling 3 Protein/genetics , Thailand
SELECTION OF CITATIONS
SEARCH DETAIL
...